期刊
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
卷 86, 期 3, 页码 232-250出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2012.09.014
关键词
Colon cancer; Immunotherapy; Cancer vaccines; Cellular therapies; Gene therapy; Targeted therapy; Jak-3; Villin
资金
- Crohn's & Colitis Foundation of America (CCFA) [1351, 2188]
- National Institutes of Health [DK-081661]
- Crohn's and Colitis Foundation of America (CCFA) Research Fellowship Award
- CCFA Career Development Award
- National Institute of Health (NIH) Basic Scientist Career Development Award [K01]
- American Gastroenterology Association (AGA) Research Scholar Award
- NIH
- CCFA
Colorectal cancer is the leading cause of cancer-related mortality in the western world. It is also the third most common cancer diagnosed in both men and women in the United States with a recent estimate for new cases of colorectal cancer in the year 2012 being around 103,170. Various risk factors for colorectal cancer include life-style, diet, age, personal and family history, and racial and ethnic background. While a few cancers are certainly preventable but this does not hold true for colon cancer as it is often detected in its advanced stage and generally not diagnosed until symptoms become apparent. Despite the fact that several options are available for treating this cancer through surgery, chemotherapy, radiation therapy, immunotherapy, and nutritional-supplement therapy, but the success rates are not very encouraging when used alone where secondary complications appear in almost all these therapies. To maximize the therapeutic-effects inpatients, combinatorial approaches are essential. In this review we have discussed the therapies previously and currently available to patients diagnosed with colorectal-cancer, focus on some recent developments in basic research that has shaded lights on new therapeutic-concepts utilizing macrophages/dendritic cells, natural killer cells, gene delivery, siRNA-, and microRNA-technology, and specific-targeting of tyrosine kinases that are either mutated or over-expressed in the cancerous cell to treat these cancer. Potential strategies are discussed where these concepts could be applied to the existing therapies under a comprehensive approach to enhance the therapeutic effects. (c) 2012 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据